Deborah Dunsire - Net Worth and Insider Trading

Deborah Dunsire Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Deborah Dunsire owns 3 companies in total, including Ultragenyx Pharmaceutical Inc (RARE) , Alexion Pharmaceuticals Inc (ALXN) , and Syros Pharmaceuticals Inc (SYRS) .

Click here to see the complete history of Deborah Dunsire’s form 4 insider trades.

Insider Ownership Summary of Deborah Dunsire

Ticker Comapny Transaction Date Type of Owner
RARE Ultragenyx Pharmaceutical Inc 2017-04-06 director
ALXN Alexion Pharmaceuticals Inc 2020-05-14 director
SYRS Syros Pharmaceuticals Inc 2021-09-09 director

Deborah Dunsire Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Deborah Dunsire Ownership Network

Ownership Network List of Deborah Dunsire

No Data

Ownership Network Relation of Deborah Dunsire

Insider Network Chart

Deborah Dunsire Owned Company Details

What does Ultragenyx Pharmaceutical Inc do?

Who are the key executives at Ultragenyx Pharmaceutical Inc?

Deborah Dunsire is the director of Ultragenyx Pharmaceutical Inc. Other key executives at Ultragenyx Pharmaceutical Inc include Chief Financial Officer Howard Horn , director & 10 percent owner & President & CEO Emil D Kakkis , and Controller and PAO Theodore Alan Huizenga .

Ultragenyx Pharmaceutical Inc (RARE) Insider Trades Summary

Over the past 18 months, Deborah Dunsire made no insider transaction in Ultragenyx Pharmaceutical Inc (RARE). Other recent insider transactions involving Ultragenyx Pharmaceutical Inc (RARE) include a net sale of 147,853 shares made by Emil D Kakkis , a net sale of 4,391 shares made by Sanders Corazon (corsee) D. , and a net sale of 3,565 shares made by Theodore Alan Huizenga .

In summary, during the past 3 months, insiders sold 27,556 shares of Ultragenyx Pharmaceutical Inc (RARE) in total and bought 0 shares, with a net sale of 27,556 shares. During the past 18 months, 260,421 shares of Ultragenyx Pharmaceutical Inc (RARE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 260,421 shares.

Ultragenyx Pharmaceutical Inc (RARE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Ultragenyx Pharmaceutical Inc Insider Transactions

No Available Data

Deborah Dunsire Mailing Address

Above is the net worth, insider trading, and ownership report for Deborah Dunsire. You might contact Deborah Dunsire via mailing address: C/o Ultragenyx Pharmaceutical Inc., 60 Leveroni Court, Novato Ca 94949.